This alteration in GH secretion, often referred to as biochemical or functional GHD, has been reported in a subgroup of patients with human immunodeficiency virus (HIV) infection as well as in patients with chronic heart failure (CHF) and are suggested to have negative impact on disease progression [149–151]. This evidence concerns the gene GH1 and congestive heart failure.